Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Flynn

Showing results (1131-1140 of 1,203) with videos related to

Pageof 121
Sort By:
Blood|June 5, 2010
Phosphatidylinositol 3-kinase-δ inhibitor CAL-101 shows promising preclinical activity in chronic lymphocytic leukemia by antagonizing intrinsic and extrinsic cellular survival signalsSarah E M Herman, Amber L Gordon, Amy J Wagner, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|June 6, 2025
Inflammation, antiretroviral therapy continuation, and HIV disease progression in postpartum women with HIVRupak Shivakoti, Mark J Giganti, Michael M Lederman, et al.
Spine Deformity|September 22, 2022
Strategies reducing risk of surgical-site infection following pediatric spinal deformity surgeryHiroko Matsumoto, Lisa Bonsignore-Opp, Shay I Warren, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|January 14, 2022
A Multicentre Retrospective Study of Fulvestrant Use and Efficacy in Advanced/Metastatic Breast CancerA Lerner, K Keshwani, A Okines, et al.
European Journal of Cancer (Oxford, England : 1990)|September 10, 2018
An extended phase Ib study of epertinib, an orally active reversible dual EGFR/HER2 tyrosine kinase inhibitor, in patients with solid tumoursH-T Arkenau, A Italiano, G Mak, et al.
Journal of Eating Disorders|September 15, 2021
Early weight gain trajectories in first episode anorexia: predictors of outcome for emerging adults in outpatient treatmentA Austin, M Flynn, K L Richards, et al.
The American Journal of Gastroenterology|October 10, 2012
Microbiota of de-novo pediatric IBD: increased Faecalibacterium prausnitzii and reduced bacterial diversity in Crohn's but not in ulcerative colitisRichard Hansen, Richard K Russell, Caroline Reiff, et al.
Antimicrobial Agents and Chemotherapy|October 28, 2005
Pharmacokinetics, safety, and tolerability of caspofungin in children and adolescentsThomas J Walsh, Peter C Adamson, Nita L Seibel, et al.
Investigational New Drugs|April 4, 2016
A phase I, dose escalation, pharmacodynamic, pharmacokinetic, and food-effect study of α2 integrin inhibitor E7820 in patients with advanced solid tumorsB Milojkovic Kerklaan, S Slater, M Flynn, et al.
Health & Justice|April 15, 2018
A model for rigorously applying the Exploration, Preparation, Implementation, Sustainment (EPIS) framework in the design and measurement of a large scale collaborative multi-site studyJennifer E Becan, John P Bartkowski, Danica K Knight, et al.
Pageof 121

Showing results (1131-1140 of 1,203) with videos related to

Sort By:
Pageof 121
Blood|June 5, 2010
Phosphatidylinositol 3-kinase-δ inhibitor CAL-101 shows promising preclinical activity in chronic lymphocytic leukemia by antagonizing intrinsic and extrinsic cellular survival signalsSarah E M Herman, Amber L Gordon, Amy J Wagner, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|June 6, 2025
Inflammation, antiretroviral therapy continuation, and HIV disease progression in postpartum women with HIVRupak Shivakoti, Mark J Giganti, Michael M Lederman, et al.
Spine Deformity|September 22, 2022
Strategies reducing risk of surgical-site infection following pediatric spinal deformity surgeryHiroko Matsumoto, Lisa Bonsignore-Opp, Shay I Warren, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|January 14, 2022
A Multicentre Retrospective Study of Fulvestrant Use and Efficacy in Advanced/Metastatic Breast CancerA Lerner, K Keshwani, A Okines, et al.
European Journal of Cancer (Oxford, England : 1990)|September 10, 2018
An extended phase Ib study of epertinib, an orally active reversible dual EGFR/HER2 tyrosine kinase inhibitor, in patients with solid tumoursH-T Arkenau, A Italiano, G Mak, et al.
Journal of Eating Disorders|September 15, 2021
Early weight gain trajectories in first episode anorexia: predictors of outcome for emerging adults in outpatient treatmentA Austin, M Flynn, K L Richards, et al.
The American Journal of Gastroenterology|October 10, 2012
Microbiota of de-novo pediatric IBD: increased Faecalibacterium prausnitzii and reduced bacterial diversity in Crohn's but not in ulcerative colitisRichard Hansen, Richard K Russell, Caroline Reiff, et al.
Antimicrobial Agents and Chemotherapy|October 28, 2005
Pharmacokinetics, safety, and tolerability of caspofungin in children and adolescentsThomas J Walsh, Peter C Adamson, Nita L Seibel, et al.
Investigational New Drugs|April 4, 2016
A phase I, dose escalation, pharmacodynamic, pharmacokinetic, and food-effect study of α2 integrin inhibitor E7820 in patients with advanced solid tumorsB Milojkovic Kerklaan, S Slater, M Flynn, et al.
Health & Justice|April 15, 2018
A model for rigorously applying the Exploration, Preparation, Implementation, Sustainment (EPIS) framework in the design and measurement of a large scale collaborative multi-site studyJennifer E Becan, John P Bartkowski, Danica K Knight, et al.
Pageof 121